Signal from the log
FIZE Medical
montant non divulgue · Series B · Israel · Medtech
FIZE Medical mesure en continu le débit urinaire des patients de réanimation, pour ajuster les perfusions avant que le rein lâche. Son système kUO est vendu au Japon par Asahi Kasei Medical, qui co-mène ce premier closing avec Rapha Capital Management. Le communiqué donne 20 M$ comme cible du tour et ne dit pas combien a été levé à ce closing.
Spotted
Announced on , logged by the watch of 17 September 2026.
- Operation
- Funding round
- Announced amount
- montant non divulgue
- Stage
- Series B
- Country
- Israel
- Sector
- Medtech
What the log says
Editorial note, in French
Repérée par la collecte. Personne ne l'a encore instruite.
The investors
Provenance
Source prnewswire
Logged on 17 September 2026
Description Written in French during the watch run. Written during the watch run, after reading the issuer's press release or the source article.
Verification Amounts and fund names were double checked against the issuer's press release or an official filing.
What this status means
Spotted The collection saw this operation and logged it. Nobody has processed it yet, so what is shown is still an automatic reading of the source headline.
The rule A signal is never removed from the log. A round set aside stays readable with its reason, because a collection you cannot reread is a collection you cannot correct.